BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but Not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0995
Full Text
Open PDFAbstract
Available in full text
Date
May 31, 2013
Authors
Publisher
American Association for Cancer Research (AACR)